Femme et Homme
- | Pays : -
- | Organes : -
- | Spécialités : -
Extrait
To demonstrate that zoledronic acid has superior efficacy compared with placebo on the percent change of bone mineral density (BMD) as assessed by the T-score at lumbar spine and total hip region at month 12 relative to screening as measured by Dual X-ray Absorptiometry (DXA) in MS patients suffering from osteoporosis.
Critère d'inclusion
- osteoporosis in patients with multiple sclerosis